Amphastar Pharmaceuticals, Inc. (AMPH)
19.96
+0.13
(+0.66%)
USD |
NASDAQ |
Mar 04, 16:00
19.75
-0.21
(-1.05%)
After-Hours: 05:40
Amphastar Pharmaceuticals EPS Diluted (Quarterly) : 0.518 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Pfizer Inc. | -0.2898 |
| Organon & Co. | -0.7879 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.43M |
| Revenue (Quarterly) | 183.10M |
| Total Expenses (Quarterly) | 158.68M |
| Enterprise Value | 1.288B |
| Gross Profit Margin (Quarterly) | 44.70% |
| Profit Margin (Quarterly) | 13.34% |
| Earnings Yield | 10.19% |
| Operating Earnings Yield | 14.59% |
| Normalized Earnings Yield | 9.853 |